Home  |  Contact

Cellosaurus HBC-4 (CVCL_B496)

[Text version]

Cell line name HBC-4
Synonyms HBC4
Accession CVCL_B496
Resource Identification Initiative To cite this cell line use: HBC-4 (RRID:CVCL_B496)
Comments Part of: JFCR39 cancer cell line panel.
Part of: JFCR45 cancer cell line panel.
Population: Japanese.
Omics: Transcriptome analysis.
Sequence variations Mutation; TP53; none detected (PubMed=15900046).
Disease Breast carcinoma (NCIt: C4872)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 72Y
Category Cancer cell line
Publications

PubMed=8882729; DOI=10.1093/oxfordjournals.jbchem.a021246
Satoh A., Takayama E., Kojima K., Ogawa H., Yamori T., Sato S., Kawaguchi T., Tsuruo T., Katsura Y., Kina T., Matsumoto I.
Expression of carbohydrate-binding protein p33/41 in human tumor cell lines.
J. Biochem. 119:346-353(1996)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T.
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)

PubMed=15900046; DOI=10.1093/jnci/dji133
Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y., Yamazaki K., Hamada J., Tada M., Moriuchi T., Ishikawa Y., Kato Y., Tomoda H., Yamori T., Tsuruo T.
p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
J. Natl. Cancer Inst. 97:765-777(2005)

PubMed=22336246; DOI=10.1016/j.bmc.2012.01.017
Kong D., Yamori T.
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Bioorg. Med. Chem. 20:1947-1951(2012)

Cross-references
Other Wikidata; Q54881371
Polymorphism and mutation databases Cosmic; 1436028
IARC_TP53; 21643
Entry history
Entry creation06-Jun-2012
Last entry update12-Jan-2021
Version number13